Allogene Therapeutics Announces Participation in December Investor Conference
SOUTH SAN FRANCISCO, Calif. , Dec. 01, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…